Supernus Pharmaceuticals Stock Volume Indicators On Balance Volume

SUPN Stock  USD 36.10  0.12  0.33%   
Supernus Pharmaceuticals volume indicators tool provides the execution environment for running the On Balance Volume indicator and other technical functions against Supernus Pharmaceuticals. Supernus Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volume indicators indicators. As with most other technical indicators, the On Balance Volume indicator function is designed to identify and follow existing trends. Supernus Pharmaceuticals volume indicators are based on Chaikin accumulation (buying pressure) and distribution (selling pressure) factors to determine the likely sustainability of a given price move.

Indicator
The output start index for this execution was zero with a total number of output elements of sixty-one. The On Balance Volume indicator was developed by Joe Granville to show time series momentum that relates Supernus Pharmaceuticals volume to price change. It can show when Supernus Pharmaceuticals is accumulated or sold by a large number of investors.

Supernus Pharmaceuticals Technical Analysis Modules

Most technical analysis of Supernus Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Supernus from various momentum indicators to cycle indicators. When you analyze Supernus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Supernus Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Supernus Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Supernus Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Supernus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Supernus Pharmaceuticals's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Supernus Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Supernus Pharmaceuticals, we also check how macroeconomic factors affect Supernus Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover8.048.2742.6644.79
Days Of Inventory On Hand417.99383.08337.24320.38
Hype
Prediction
LowEstimatedHigh
34.0036.0738.14
Details
Intrinsic
Valuation
LowRealHigh
32.4938.6240.69
Details
4 Analysts
Consensus
LowTargetHigh
38.4542.2546.90
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.710.710.72
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Supernus Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Supernus Pharmaceuticals' short interest history, or implied volatility extrapolated from Supernus Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Casinos Idea
Casinos
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Momentum Idea
Momentum
Invested over 40 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Chemicals Idea
Chemicals
Invested over 30 shares
FinTech Idea
FinTech
Invested over 60 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Supernus Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Supernus Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Supernus Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Supernus Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Supernus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Supernus Pharmaceuticals. If investors know Supernus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Supernus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
1.07
Revenue Per Share
11.877
Quarterly Revenue Growth
0.142
Return On Assets
0.0289
The market value of Supernus Pharmaceuticals is measured differently than its book value, which is the value of Supernus that is recorded on the company's balance sheet. Investors also form their own opinion of Supernus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Supernus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Supernus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Supernus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Supernus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Supernus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Supernus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.